Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Stronati

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Chronobiology International|August 14, 2012
Association study of a polymorphism in clock gene PERIOD3 and risk of inflammatory bowel diseaseGianluigi Mazzoccoli, Orazio Palmieri, Giuseppe Corritore, et al.
Plos One|December 16, 2016
Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre TrialClaudia Della Corte, Guido Carpino, Rita De Vito, et al.
Plos One|May 2, 2013
Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel diseaseAnna Latiano, Orazio Palmieri, Luca Pastorelli, et al.
International Archives of Occupational and Environmental Health|November 3, 2014
Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approachMassimo Moretti, Maria Giuseppa Grollino, Sofia Pavanello, et al.
Oncotarget|November 18, 2015
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver diseaseSara Ceccarelli, Nadia Panera, Marco Mina, et al.
BMC Public Health|April 1, 2011
A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric projectMassimo Moretti, Roberta Bonfiglioli, Donatella Feretti, et al.
Journal of Medicinal Chemistry|April 26, 2016
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 KinasePamela A Haile, Bartholomew J Votta, Robert W Marquis, et al.
Nature Genetics|November 25, 2010
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociAndre Franke, Dermot P B McGovern, Jeffrey C Barrett, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Chronobiology International|August 14, 2012
Association study of a polymorphism in clock gene PERIOD3 and risk of inflammatory bowel diseaseGianluigi Mazzoccoli, Orazio Palmieri, Giuseppe Corritore, et al.
Plos One|December 16, 2016
Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre TrialClaudia Della Corte, Guido Carpino, Rita De Vito, et al.
Plos One|May 2, 2013
Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel diseaseAnna Latiano, Orazio Palmieri, Luca Pastorelli, et al.
International Archives of Occupational and Environmental Health|November 3, 2014
Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approachMassimo Moretti, Maria Giuseppa Grollino, Sofia Pavanello, et al.
Oncotarget|November 18, 2015
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver diseaseSara Ceccarelli, Nadia Panera, Marco Mina, et al.
BMC Public Health|April 1, 2011
A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric projectMassimo Moretti, Roberta Bonfiglioli, Donatella Feretti, et al.
Journal of Medicinal Chemistry|April 26, 2016
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 KinasePamela A Haile, Bartholomew J Votta, Robert W Marquis, et al.
Nature Genetics|November 25, 2010
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociAndre Franke, Dermot P B McGovern, Jeffrey C Barrett, et al.
Pageof 7